Raquel T. Lima

8.4k total citations
73 papers, 2.1k citations indexed

About

Raquel T. Lima is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Raquel T. Lima has authored 73 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 15 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Raquel T. Lima's work include MicroRNA in disease regulation (13 papers), RNA Interference and Gene Delivery (9 papers) and Extracellular vesicles in disease (8 papers). Raquel T. Lima is often cited by papers focused on MicroRNA in disease regulation (13 papers), RNA Interference and Gene Delivery (9 papers) and Extracellular vesicles in disease (8 papers). Raquel T. Lima collaborates with scholars based in Portugal, Brazil and Spain. Raquel T. Lima's co-authors include M. Helena Vasconcelos, Diana Sousa, José E. Guimarães, Madalena Pinto, Hugo Seca, Vanessa Lopes-Rodrigues, Gabriela M. Almeida, Isabel C.F.R. Ferreira, Dean A. Fennell and Giovanni Gaudino and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Raquel T. Lima

70 papers receiving 2.0k citations

Peers

Raquel T. Lima
Hye Jin Jung South Korea
Raquel T. Lima
Citations per year, relative to Raquel T. Lima Raquel T. Lima (= 1×) peers Hye Jin Jung

Countries citing papers authored by Raquel T. Lima

Since Specialization
Citations

This map shows the geographic impact of Raquel T. Lima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raquel T. Lima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raquel T. Lima more than expected).

Fields of papers citing papers by Raquel T. Lima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raquel T. Lima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raquel T. Lima. The network helps show where Raquel T. Lima may publish in the future.

Co-authorship network of co-authors of Raquel T. Lima

This figure shows the co-authorship network connecting the top 25 collaborators of Raquel T. Lima. A scholar is included among the top collaborators of Raquel T. Lima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raquel T. Lima. Raquel T. Lima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soares, Paula, et al.. (2025). Nanostructured lipid carriers for enhanced batimastat delivery across the blood–brain barrier: an in vitro study for glioblastoma treatment. Drug Delivery and Translational Research. 15(8). 2794–2813. 5 indexed citations
2.
Soares, Paula, et al.. (2025). Emerging Approaches in Glioblastoma Treatment: Modulating the Extracellular Matrix Through Nanotechnology. Pharmaceutics. 17(2). 142–142. 6 indexed citations
3.
Paula, Arnaud Da Cruz, Raquel T. Lima, Rui Batısta, et al.. (2024). Investigating USP42 Mutation as Underlying Cause of Familial Non-Medullary Thyroid Carcinoma. International Journal of Molecular Sciences. 25(3). 1522–1522.
4.
Pereira, A.T., et al.. (2024). Scale for Body Image Concerns During the Perinatal Period – Adaptation and validation. European Psychiatry. 67(S1). S159–S160. 1 indexed citations
5.
Peixoto, Joana, Ana Pestana, Hugo Osório, et al.. (2023). Using a Dual CRISPR/Cas9 Approach to Gain Insight into the Role of LRP1B in Glioblastoma. International Journal of Molecular Sciences. 24(14). 11285–11285. 8 indexed citations
6.
Mota, Rita, Raquel T. Lima, Carlos Flores, et al.. (2023). Assessing the Antitumor Potential of Variants of the Extracellular Carbohydrate Polymer from Synechocystis ΔsigF Mutant. Polymers. 15(6). 1382–1382.
7.
Peixoto, Joana, Sofia Macedo, Jorge Pinheiro, et al.. (2023). High VEGFA Expression Is Associated with Improved Progression-Free Survival after Bevacizumab Treatment in Recurrent Glioblastoma. Cancers. 15(8). 2196–2196. 6 indexed citations
8.
Magro, Fernando, et al.. (2017). An overview on the role of autophagy in cancer therapy. 2(1). 12 indexed citations
9.
Lopes-Rodrigues, Vanessa, Ana Oliveira, Marta Correia‐da‐Silva, et al.. (2016). A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells. Bioorganic & Medicinal Chemistry. 25(2). 581–596. 52 indexed citations
10.
Lopes-Rodrigues, Vanessa, Alessio Di Luca, Diana Sousa, et al.. (2016). Data supporting the shedding of larger extracellular vesicles by multidrug resistant tumour cells. Data in Brief. 6. 1023–1027. 9 indexed citations
11.
Vizetto‐Duarte, Catarina, Luísa Custódio, Gerardo Acosta, et al.. (2016). Can macroalgae provide promising anti-tumoral compounds? A closer look at Cystoseira tamariscifolia as a source for antioxidant and anti-hepatocarcinoma compounds. PeerJ. 4. e1704–e1704. 32 indexed citations
12.
Ferreira, Isabel C.F.R., Marina Sokóvić, Leo van Griensven, et al.. (2015). Cordyceps militaris (L.) Link Fruiting Body Reduces the Growth of a Non-Small Cell Lung Cancer Cell Line by Increasing Cellular Levels of p53 and p21. Molecules. 20(8). 13927–13940. 19 indexed citations
13.
Teixeira, Maribel, Carlos Maurı́cio Barbosa, Raquel T. Lima, et al.. (2013). Development of noncytotoxic PLGA nanoparticles to improve the effect of a new inhibitor of p53–MDM2 interaction. International Journal of Pharmaceutics. 454(1). 394–402. 17 indexed citations
14.
Lima, Raquel T., Joanna Grabowska, Giovanna Bermano, et al.. (2013). Cytotoxicity and Cell Death Mechanisms Induced by a Novel Bisnaphthalimidopropyl Derivative against the NCI-H460 non-small Lung Cancer Cell Line. Anti-Cancer Agents in Medicinal Chemistry. 13(3). 414–421. 10 indexed citations
15.
Afonso, Carlos, Diana Sousa, Raquel T. Lima, et al.. (2013). Multidimensional optimization of promising antitumor xanthone derivatives. Bioorganic & Medicinal Chemistry. 21(11). 2941–2959. 17 indexed citations
16.
Cidade, Honorina, Madalena Pinto, Artur M. S. Silva, et al.. (2011). Prenylated derivatives of baicalein and 3,7-dihydroxyflavone: Synthesis and study of their effects on tumor cell lines growth, cell cycle and apoptosis. European Journal of Medicinal Chemistry. 46(6). 2562–2574. 58 indexed citations
17.
Queiroz, Maria João R.P., Ricardo C. Calhelha, Luís A. Vale-Silva, et al.. (2010). Efficient synthesis of 6-(hetero)arylthieno[3,2-b]pyridines by Suzuki–Miyaura coupling. Evaluation of growth inhibition on human tumor cell lines, SARs and effects on the cell cycle. European Journal of Medicinal Chemistry. 45(12). 5628–5634. 28 indexed citations
18.
Lima, Raquel T., Hugo Seca, Paula Soares, María Säo José Nascimento, & M. Helena Vasconcelos. (2010). EBV interferes with the sensitivity of Burkitt lymphoma Akata cells to etoposide. Journal of Cellular Biochemistry. 112(1). 200–210. 6 indexed citations
19.
Lima, Raquel T., et al.. (2006). Chemosensitization Effects of XIAP Downregulation in K562 Leukemia Cells. Journal of Chemotherapy. 18(1). 98–102. 28 indexed citations
20.
Carvalho, Mamede de, Reinhold P. Linke, Teresinha Evangelista, et al.. (2004). Mutant fibrinogen A-α-chain associated with hereditary renal amyloidosis and peripheral neuropathy. Amyloid. 11(3). 200–207. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026